One of the most important debates among health economists in rich nations is whether advances in biotechnology will spare their health care systems from a financial crisis. We must consider that prevalence rates of chronic diseases declined during the twentieth century and that this rate of...

Cover; Half Title; Title; Copyright Page; Contents; Preface; Acknowledgments; About the Editors; About the Contributors; Contributors; Introduction; Part I: The Americas; Paul Shekelle; 1: Argentina: Achieving Universal Coverage; Hugo Arce, Ezequiel García-Elorrio, and Viviana Rodríguez; 2: Brazil:...

One of the most important debates among health economists in rich nations is whether advances in biotechnology will spare their health care systems from a financial crisis. We must consider that prevalence rates of chronic diseases declined during the twentieth century and that this rate of...